MedPath

Electrotherapy in the treatment of pain during intercourse and assessment of the outcomes on the quality of life and sexuality of women with deep endometriosis

Not Applicable
Recruiting
Conditions
Endometriosis. Dyspareunia.
C12.294.644.242
C13.351.500.163
Registration Number
RBR-3rndh6
Lead Sponsor
Ticiana Aparecida Alves de Mira
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Sexually active women. Women in menacme. Diagnosis of endometriosis estages III, IV and/or of the rectovaginal septum. Deep dyspareunia.

Exclusion Criteria

Decreased skin sensitivity preventing the perception of the electric stimulus. Pregnant women. Pacemaker users. Hypersensitivity (allergic reactions to the gel or electrode). Epilepsy. Heart disease (arrhythmia). Osteosynthesis at the application site. Open sores. Malignant tumors. Acute inflammatory disease. Other associated gynecological pathologies. Cognitive disabilities that prevente the understanding of the use of the tools and/or conventional electrotherapeutic treatment or do not understand instructions for the use of the self-applied TENS.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deep dyspareunia relief and/or resolution analyzed through the visual analogue scale from the variance observed at least 5% of the pre and post treatment results.
Secondary Outcome Measures
NameTimeMethod
Improvement at quality of life measured through a whoqol-bref quality of life questionnaire plus an endometriosis quality of life questionnaire from observations of 5% significance in the pre and post treatment results.;Sexuality improvement measured through the Female Sexual Function Index from observations of 5% significance in the pre and post treatment results.
© Copyright 2025. All Rights Reserved by MedPath